CG

Column Group Portfolio holdings

AUM $65.7M
This Quarter Return
+44.63%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
10 Year Return
AUM
$1.1B
AUM Growth
Cap. Flow
+$1.1B
Cap. Flow %
100%
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$467M 42.31%
+15,396,116
New +$467M
NRIX icon
2
Nurix Therapeutics
NRIX
$714M
$177M 16.06%
+5,383,333
New +$177M
ORIC icon
3
Oric Pharmaceuticals
ORIC
$994M
$161M 14.64%
+4,768,181
New +$161M
RVMD icon
4
Revolution Medicines
RVMD
$7.1B
$142M 12.86%
+3,580,252
New +$142M
RAPT icon
5
RAPT Therapeutics
RAPT
$188M
$76.7M 6.96%
+3,885,679
New +$76.7M
CNST
6
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$75.6M 6.86%
+2,626,631
New +$75.6M
GRTS
7
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$3.43M 0.31%
+869,493
New +$3.43M